Trade Report: Today: Research Analysts’ Updated EPS Estimates for November, 28th (AAAP, ADNT, ASH, CIEN, CNMD, COST, ENZY, EPZM, HZNP, IDRA)

Today: Research Analysts’ Updated EPS Estimates for November, 28th (AAAP, ADNT, ASH, CIEN, CNMD, COST, ENZY, EPZM, HZNP, IDRA)

Research Analysts’ updated eps estimates for Monday, November 28th:

Advanced Accelerator Applications SA (NASDAQ:AAAP) had its buy rating reissued by analysts at Canaccord Genuity. Canaccord Genuity currently has a $47.00 price target on the stock.

Susquehanna began coverage on shares of Adient plc (NYSE:ADNT). Susquehanna issued a neutral rating and a $56.00 price target on the stock.

Ashland (NYSE:ASH) had its buy rating reissued by analysts at Deutsche Bank AG. The firm currently has a $125.00 price target on the stock.

Ciena Corp. (NYSE:CIEN) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $30.00 price target on the stock.

Conmed Corp. (NASDAQ:CNMD) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CONMED Corporation reported impressive third-quarter 2016 results wherein revenues surpassed the Zacks Consensus Estimate and increased on a year-over-year basis. However, earnings were in-line with the estimate mark. Foreign exchange movements have been unfavorably impacting the company’s results of late. Additionally, CONMED operates in a highly competitive environment that includes competition from companies like Johnson & Johnson, Medtronic, Smith & Nephew, Stryker Corporation, and others which are likely to mar the top-line growth. Declining Orthopaedic surgery sales, especially in the U.S. in the last reported quarter is an added concern. Nevertheless, the company anticipates strong revenue contribution from the AirSeal system (SurgiQuest) for full-year 2016.”

Costco Wholesale Corp. (NASDAQ:COST) had its outperform rating reissued by analysts at Robert W. Baird.

Enzymotec (NASDAQ:ENZY) had its hold rating reiterated by analysts at Jefferies Group. Jefferies Group currently has a $7.00 price target on the stock, down from their previous price target of $8.00.

Epizyme (NASDAQ:EPZM) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $22.00 price target on the stock.

Horizon Pharma (NASDAQ:HZNP) had its outperform rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $29.00 price target on the stock.

Idera Pharmaceuticals (NASDAQ:IDRA) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $6.00 target price on the stock.

Kroger (NYSE:KR) had its buy rating reissued by analysts at Guggenheim. Guggenheim currently has a $40.00 target price on the stock.

Kroger (NYSE:KR) had its sector perform rating reissued by analysts at RBC Capital Markets. The firm currently has a $37.00 target price on the stock.

Lions Gate Entertainment Corp. (NYSE:LGF) had its buy rating reiterated by analysts at Brean Capital. Brean Capital currently has a $27.00 price target on the stock.

3M (NYSE:MMM) had its buy rating reiterated by analysts at Jefferies Group. They currently have a $210.00 target price on the stock, up from their previous target price of $200.00.

MakeMyTrip (NASDAQ:MMYT) had its buy rating reissued by analysts at Jefferies Group.

OraSure Technologies (NASDAQ:OSUR) had its buy rating reiterated by analysts at Canaccord Genuity. They currently have a $10.00 target price on the stock.

Pure Storage (NYSE:PSTG) had its buy rating reaffirmed by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $20.00 price target on the stock.

PVH Corp. (NYSE:PVH) had its buy rating reaffirmed by analysts at Piper Jaffray Cos.. Piper Jaffray Cos. currently has a $124.00 target price on the stock.

Splunk (NASDAQ:SPLK) had its buy rating reaffirmed by analysts at Drexel Hamilton. The analysts wrote, “We believe Splunk will slightly exceed our 3Q:FY17 revenue estimate of $229.7 million (up 32% YoY; Street is at $230.3 million) and meet our EPS projection of $0.07 (Street is at $0.08). Recall, Splunk’s 3Q:FY17 outlook calls for sales of $228-230 million.””

Southwestern Energy (NYSE:SWN) was upgraded by analysts at Robert W. Baird from a market perform rating to an outperform rating. The firm currently has $18.00 target price on the stock.

Related posts

Leave a Comment